TBC1D22A and cancer: By analyzing the pan-cancer data (Supplementary Figures S3, S4), it was found that TBC1D22A also has a prognostic value in esophageal carcinoma (ESCA) and liver hepatocellular carcinoma (LIHC), which needs further research in related fields.